LDLR and familial hyperaldosteronism: In the present work, we derive and perform a detailedcharacterisationof the isogenic genetically modified iPSCline ICGi036-A-1 by base editing correction of LDLR allelicvariants in the original iPSC line previously obtained froma compound heterozygous FH patient carrying pathogenicc.530C>T (p.Ser177Leu) and likely pathogenic c.1054T>C(p.Cys352Arg) LDLR alleles.